Bosnalijek d.d.

home

dobrodošli

19.1.2012 Intensive development of international business
According to preliminary results in 2011, Bosnalijek d.d. (Bosnalijek) realised total sales revenue in the amount of 106.5 million KM, with a 5% growth compared to year 2010. In the market of Bosnia and Herzegovina, sales revenue totalled 50.3 million, and 56.2 million KM was achieved in export.

26.12.2011 Bosnalijek Donated Surgical Equipment to University Clinical Centre Tuzla and HPLC Apparatus to Faculty of Pharmacy in Tuzla

5.12.2011 BiH DRUG MARKET REGULATION REQUIRES PARTNER APPROACH OF ALL RESPONSIBLE ACTIVE PARTICIPANTS




		Bronchobos stops cough and makes easier breathing

		How to eliminate symptoms of cold and flu?

		Top quality Bostrombin is recommended

		Royal Jelly - natural stimulant of the organism

		Golderm - Unique product for rapid healing of the skin

		Golderm gel - Rapidly renews damaged skin

SASE stock exchange

Date:03.02.2012 › Price:7,88 KM › Change:-2,32%â › Best buy:7,81 KM › Best sell:7,85 KM › Volume:19.446 › Value:153.287,23 KM › Number of transactions:17 › Shares issued:7.829.987 › Market cap:61.700.297,56 KM


		Annual reports

		Audited financial reports

Bosnalijek sponzors school of diagnostic gastrointestinal endoscopy

Bosnalijek product overview